200 related articles for article (PubMed ID: 3001366)
41. Uncoating of human rhinovirus serotype 2 from late endosomes.
Prchla E; Kuechler E; Blaas D; Fuchs R
J Virol; 1994 Jun; 68(6):3713-23. PubMed ID: 8189509
[TBL] [Abstract][Full Text] [Related]
42. The rhinoviruses of man.
Fiala M; Guze LB
Calif Med; 1970 May; 112(5):1-6. PubMed ID: 4322204
[TBL] [Abstract][Full Text] [Related]
43. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1.
Tomassini JE; Graham D; DeWitt CM; Lineberger DW; Rodkey JA; Colonno RJ
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4907-11. PubMed ID: 2544880
[TBL] [Abstract][Full Text] [Related]
44. Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.
Martin S; Casasnovas JM; Staunton DE; Springer TA
J Virol; 1993 Jun; 67(6):3561-8. PubMed ID: 8098781
[TBL] [Abstract][Full Text] [Related]
45. Soluble LDL minireceptors. Minimal structure requirements for recognition of minor group human rhinovirus.
Marlovits TC; Abrahamsberg C; Blaas D
J Biol Chem; 1998 Dec; 273(50):33835-40. PubMed ID: 9837974
[TBL] [Abstract][Full Text] [Related]
46. Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells.
Harris JR; Racaniello VR
J Virol; 2005 May; 79(9):5363-73. PubMed ID: 15827151
[TBL] [Abstract][Full Text] [Related]
47. Rhinoviruses replicate effectively at lower airway temperatures.
Papadopoulos NG; Sanderson G; Hunter J; Johnston SL
J Med Virol; 1999 May; 58(1):100-4. PubMed ID: 10223554
[TBL] [Abstract][Full Text] [Related]
48. Human rhinovirus 3 at 3.0 A resolution.
Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
[TBL] [Abstract][Full Text] [Related]
49. Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.
Staunton DE; Gaur A; Chan PY; Springer TA
J Immunol; 1992 May; 148(10):3271-4. PubMed ID: 1349619
[TBL] [Abstract][Full Text] [Related]
50. Antigenic groupings of 90 rhinovirus serotypes.
Cooney MK; Fox JP; Kenny GE
Infect Immun; 1982 Aug; 37(2):642-7. PubMed ID: 6288568
[TBL] [Abstract][Full Text] [Related]
51. Avian homologs of the mammalian low-density lipoprotein receptor family bind minor receptor group human rhinovirus.
Gruenberger M; Wandl R; Nimpf J; Hiesberger T; Schneider WJ; Kuechler E; Blaas D
J Virol; 1995 Nov; 69(11):7244-7. PubMed ID: 7474146
[TBL] [Abstract][Full Text] [Related]
52. Anti-idiotypic antibodies to monoclonal antibodies that neutralize coxsackievirus B4 do not recognize viral receptors.
McClintock PR; Prabhakar BS; Notkins AL
Virology; 1986 Apr; 150(2):352-60. PubMed ID: 3962185
[TBL] [Abstract][Full Text] [Related]
53. Distinct cellular receptor interactions in poliovirus and rhinoviruses.
Xing L; Tjarnlund K; Lindqvist B; Kaplan GG; Feigelstock D; Cheng RH; Casasnovas JM
EMBO J; 2000 Mar; 19(6):1207-16. PubMed ID: 10716921
[TBL] [Abstract][Full Text] [Related]
54. Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.
Garozzo A; Cutrì CC; Castro A; Tempera G; Guerrera F; Sarvà MC; Geremia E
Antiviral Res; 2000 Mar; 45(3):199-210. PubMed ID: 10771083
[TBL] [Abstract][Full Text] [Related]
55. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196.
Fang F; Yu M
J Antimicrob Chemother; 2004 Jan; 53(1):23-5. PubMed ID: 14657090
[TBL] [Abstract][Full Text] [Related]
56. Different pH requirements for entry of the two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus.
Madshus IH; Olsnes S; Sandvig K
Virology; 1984 Dec; 139(2):346-57. PubMed ID: 6097029
[TBL] [Abstract][Full Text] [Related]
57. Visualization of single receptor molecules bound to human rhinovirus under physiological conditions.
Kienberger F; Rankl C; Pastushenko V; Zhu R; Blaas D; Hinterdorfer P
Structure; 2005 Sep; 13(9):1247-53. PubMed ID: 16154082
[TBL] [Abstract][Full Text] [Related]
58. Production and properties of site-specific antibodies to synthetic peptide antigens related to potential cell surface receptor sites for rhinovirus.
McCray J; Werner G
Methods Enzymol; 1989; 178():676-92. PubMed ID: 2557528
[No Abstract] [Full Text] [Related]
59. Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA.
Hewat EA; Blaas D
J Virol; 2006 Dec; 80(24):12398-401. PubMed ID: 17005641
[TBL] [Abstract][Full Text] [Related]
60. Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.
Schober D; Kronenberger P; Prchla E; Blaas D; Fuchs R
J Virol; 1998 Feb; 72(2):1354-64. PubMed ID: 9445036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
